RRP12 (Q5JTH9) - a pre-40S export factor in six of seven MLL-fusion interactomes but NOT in the index fusion's, and the block's only member with a recessive human disease published in 2025
also called RRP12 · KIAA0690 · RRP12-like protein
RRP12 is a large nucleolar protein that helps finished ribosome parts leave the nucleolus for the cytoplasm. It co-purifies with six of the seven MLL fusions tested - but not with the one this project studies.
The same thing, for a scientist
RRP12 (Q5JTH9, 1297 aa) is a HEAT-repeat nucleolar factor required for the late nucleolar assembly steps and nuclear export of pre-40S particles, working alongside the exportin Crm1 [E2]; in yeast it additionally has ribosome-synthesis-unrelated roles in cell-cycle progression and the DNA damage response, via a karyopherin-dependent import route [E3]. **It is recovered by six of the seven MLL fusions and is absent from the MLL-AF4 column entirely** - there is no p-value and no spectral count for RRP12 under the index bait [E1]. That makes it the best-supported member of the nucleolar block among those the index fusion did not recover, and it is the sharpest single illustration of why a pooled block statement is not a per-bait one. In 2025 RRP12 became the block's only member with a newly published recessive human disease: biallelic RRP12 variants cause autosomal recessive primary brain calcifications with generalized dystonia [E4]. There is no reported haematopoietic phenotype. PubMed returns ZERO records pairing RRP12 with KMT2A, MLL or t(4;11) [E5].
Six of seven, and not the one that matters here
The baits that recovered RRP12 are MLL-AF1p, MLL-AF9, MLL-CBP, MLL-EEN, MLL-ENL and MLL-GAS7 - every bait except MLL-AF4. Negative control zero 1.
That is worth stating plainly because it is counter-intuitive. On the pooled count RRP12 is tied with LYAR and PA2G4 as the joint-second-best-supported protein in the block, behind only the pan-fusion TBL3 and NOLC1. On the question this project actually asks - what binds KMT2A::AFF1 - it has no measurement at all.
And the reason is not necessarily biological. MLL-AF4 is the shallowest of the seven baits by spectral counts, so absence from its column is partly a detection-depth property. Both readings are available and neither is established: RRP12 may be a genuine MLL-fusion partner that the index bait was too shallow to catch, or it may be a partner of the other fusions that the index fusion does not make. The data cannot distinguish them, and this entry does not pretend otherwise.
What RRP12 does
In yeast, Rrp12 is required for the exit of pre-40S particles to the cytoplasm and for the proper maturation dynamics of upstream 90S pre-ribosomes; eliminating it causes accumulation of nucleoplasmic 90S-to-pre-40S transitional particles, abnormal 35S pre-rRNA processing, delayed elimination of processing by-products and no export of intermediate pre-40S complexes. The exportin Crm1 is required for the same step 2.
The Crm1 dependence is worth flagging inside this graph specifically, because this repo carries an export-axis beat and an XPO1/CRM1 thread. That is a topical adjacency and nothing more - the yeast result is about ribosome export, not about a fusion protein, and no experiment connects the two.
Separately, a yeast functional screen found Rrp12 has roles in cell-cycle progression and the DNA damage response that are unrelated to ribosome synthesis, via a karyopherin Kap121-dependent import route 3. So RRP12 is a second member of this block, with TCOF1, whose non-ribosomal function touches genome integrity.
The 2025 human disease, and what it does and does not license
Exome sequencing in two unrelated Pakistani patients with generalized dystonia and primary brain calcifications identified RRP12 as the candidate gene, which was then investigated in French (n = 111) and Chinese (n = 543) brain-calcification cohorts 4. This is the only member of the nucleolar block to acquire a named recessive human disease during the lifetime of this project.
What it licenses: RRP12 loss of function has consequences in humans, in a specific tissue, and the gene is under selection. It is also the source of UniProt's current experimental nucleolar localisation call for human RRP12.
What it does not license: any haematopoietic inference. The phenotype is neurological and calcific, and no blood phenotype is reported. Contrast TBL3, whose zebrafish mutant loses T cells and HSPCs - that comparison is the reason this entry does not claim lineage relevance for RRP12.
| uniprot | Q5JTH9 |
|---|---|
| length AA | 1297 |
| accession resolution | Resolved live 2026-09-21: gene_exact:RRP12 AND organism_id:9606 AND reviewed:true returns EXACTLY ONE reviewed row - Q5JTH9, RRP12_HUMAN, gene_primary RRP12, synonym KIAA0690, 1297 aa, protein name 'RRP12-like protein'. Primary gene name equals the symbol queried (rule 62 satisfied). data/symbol-collisions.json checked per rule 88: no row for RRP12 or KIAA0690. |
| localization | Nucleus, nucleolus (UniProt Q5JTH9, ECO:0000269 citing PubMed 12429849 and 41059649); additionally 'Nucleus membrane, single-pass membrane protein' carried as ECO:0000305/ECO:0000255, i.e. curator inference and sequence prediction, NOT an experimental call. Fetched 2026-09-21. |
| subnuclear localization | NUCLEOLUS, experimentally, compartment-level only. NO fibrillar-centre / DFC / GC assignment exists in UniProt or in the literature this beat read - a BOUNDED ABSENCE. Functionally RRP12 acts at the late nucleolar-to-nucleoplasmic transition of pre-40S particles, which implies a granular-component-to-nucleoplasm trajectory rather than a fixed sub-compartment, and that is a functional inference and is labelled as one. NOTE per rule 91: the nuclear-membrane line in UniProt is ECO:0000305 curator inference plus a sequence-based single-pass prediction, not a measurement, and should not be quoted as a second localisation. |
| localization shown for fusion | NO - nobody has imaged RRP12 in any KMT2A-rearranged cell, and the index fusion did not recover it in the one relevant AP-MS experiment. |
| shown for fusion | MLL-AF1p, MLL-AF9, MLL-CBP, MLL-EEN, MLL-ENL and MLL-GAS7 by co-purification in Jurkat. NOT MLL-AF4 - the index fusion did not recover it. shRNA-screened against MLL-AF9 in MOLM-13, score unpublished. NO independent experiment ties RRP12 to any KMT2A fusion. |
| selectivity | UNKNOWN. Not among the paper's named non-selectivity controls (RFC1, SF3A3, CCT3), but only 40 of 128 entered that re-screen and they are not named, so that carries no information. Independently: a conserved, essential pre-40S export factor is a housekeeping dependency in every proliferating cell. Not nominated as a target - and it could not be nominated as an index-fusion target in any case, since the index fusion never recovered it. |
| functional screen | FUNCTIONAL SCREEN. Supplementary Data 2 (MOESM5) is the shRNA library for the negative-selection screen: 768 data rows, 128 unique gene symbols, EXACTLY six shRNAs each -- counted with openpyxl by this beat on 2026-09-21, and this protein's symbol IS in it with six shRNAs. So it was functionally tested against an MLL fusion (MLL-AF9 in MOLM-13), which is more than a co-purification. But per-gene scores are published only as the heatmaps in Fig. 2c/2d with no table anywhere in the paper or its five supplementary files, so the outcome for this protein is not recoverable: measured-not-reported. |
| absence class | measured-not-reported |
| absence class note | Three distinct absences for this protein, worth separating. (a) The MLL-AF9 MOLM-13 shRNA score EXISTS and is heatmap-only: measured-not-reported. (b) A KMT2A::AFF1 binding measurement was ATTEMPTED and returned nothing - RRP12 is not in the MLL-AF4 column of a 300-prey ranked list. That is a weak negative rather than an absence of data, and it is the only protein-level negative evidence this beat has about the index fusion. (c) Any RRP12 experiment in a B-lineage or infant cell is never-measured. PRIDE checked: PXD009338 is the only relevant deposition, and re-analysing its MLL-AF4 raw files at lower stringency would directly address (b). |
| graph context | RRP12 appeared in 2 node files before this entry, both as a list member in nucleolar-block enumerations, and had no entry of its own. Siblings: gene-tbl3, gene-nolc1 (read before writing, neither edited), and the rest of this beat's folder. |
skucha 2018
{
"bait": "MLL-AF4 (= KMT2A::AFF1)",
"in_the_index_bait_column": false,
"p_value_mll_af4": null,
"index_bait_note": "ABSENT from the MLL-AF4 column entirely - no p-value, no spectral count. RRP12 is an MLL-FUSION interactor, NOT a demonstrated KMT2A::AFF1 interactor.",
"n_fusions_of_seven": 6,
"negative_control_spectra": 0,
"baits_that_recovered_it": [
"MLL-AF1p",
"MLL-AF9",
"MLL-CBP",
"MLL-EEN",
"MLL-ENL",
"MLL-GAS7"
],
"baits_that_did_not": [
"MLL-AF4"
],
"reading": "Joint-second-best-supported protein in the nucleolar block on the pooled count (6 of 7, with LYAR and PA2G4), and ZERO measurement in the index fusion's own column. The single sharpest illustration in this beat of why pooled is not per-bait.",
"source": "n_fusions supplied pre-verified by the coordinator from the cached MOESM4 xlsx; per-bait membership independently reproduced by this beat 2026-09-21 by re-running analyses/mll-fusion-interactome-complexes/run.py, which confirms RRP12 in the AF1p, AF9, CBP, EEN, ENL and GAS7 lists and absent from the AF4 list."
}complex membership
{
"complex": "Nucleolar / ribosome biogenesis; HEAT-repeat pre-40S nuclear export factor, Crm1-dependent; also cell-cycle and DNA-damage roles in yeast",
"block_enrichment": "15 of 26 subunits present in the 960-protein network, 1.25 expected, hypergeometric p = 6.99e-14, q(BH) = 8.39e-13 - the top-ranked of twelve complexes tested, ahead of the CCT/TRiC negative control (q = 1.4e-09) and the SEC positive control (q = 1.5e-09). Re-run by this beat 2026-09-21.",
"per_bait_subunits_of_26": {
"MLL-AF1p": 8,
"MLL-AF4": 7,
"MLL-AF9": 12,
"MLL-CBP": 10,
"MLL-EEN": 12,
"MLL-ENL": 11,
"MLL-GAS7": 7
},
"index_bait_members": [
"GNL2",
"LYAR",
"NOLC1",
"NOP2",
"PA2G4",
"TBL3",
"TCOF1"
],
"members_ABSENT_from_the_index_bait_column": [
"RRP12",
"WDR18",
"UTP14A",
"RRP9",
"UTP18",
"FTSJ3",
"FBL",
"NOP58"
],
"background_caveat": "The hypergeometric background is the ~20,000-protein proteome, not the ~4,600 proteins actually recovered before filtering, so q is an UPPER BOUND on significance and is loosest for a complex of abundant nuclear proteins."
}cell types and states
[ "Jurkat (human T-ALL) - AP-MS host, nuclear lysate; recovered by six baits but NOT by MLL-AF4", "MOLM-13 (human MLL-AF9 AML) - shRNA screen host, six shRNAs, per-gene score unpublished", "Saccharomyces cerevisiae - pre-40S export, 90S maturation, cell cycle and DNA damage response", "human patients - biallelic RRP12 variants, generalized dystonia and primary brain calcifications; NO haematopoietic phenotype reported", "no leukaemia cell outside the two screen hosts; no B-lineage, no infant, no KMT2A::AFF1 cell" ]
bounded literature
{
"query": "(RRP12[tiab] OR KIAA0690[tiab]) AND (KMT2A[tiab] OR MLL[tiab] OR \"MLL-AF4\"[tiab] OR \"MLL-AF9\"[tiab] OR \"t(4;11)\"[tiab])",
"querytranslation": "\"RRP12\"[Title/Abstract] AND (\"KMT2A\"[Title/Abstract] OR \"MLL\"[Title/Abstract] OR \"MLL-AF4\"[Title/Abstract] OR \"MLL-AF9\"[Title/Abstract] OR \"t 4 11\"[Title/Abstract])",
"count": 0,
"date": "2026-09-21",
"tool": "NCBI esearch db=pubmed",
"names_tried": [
"RRP12",
"KIAA0690"
],
"positive_control": "MEN1[tiab] AND the identical five-term KMT2A clause returns 85, through the same query shape.",
"operand_control": "The bare gene operand is non-zero, so the instrument can return a one for this symbol.",
"bound": "Titles and abstracts only; supporting figures and full texts NOT searched. The cytogenetic term is quoted and the querytranslation shows 't 4 11'[Title/Abstract] with no injected [UID] term, so rule 95 is satisfied. One [tiab] tag per term, so rule 94 is satisfied.",
"note": "Zero records. The retired/clone symbol KIAA0690 was included per the retired-symbol rule."
}- RRP12 is an essential, conserved pre-40S export factor. Any inhibitor is a general ribosome-biogenesis inhibitor with the ribosomopathy toxicity profile that implies in an infant.
- Biallelic loss in humans causes brain calcification and dystonia. That is the organ this disease's survivors are already at risk in from CNS-directed therapy.
- The most important bite-back is evidential, not pharmacological: if RRP12 is ever quoted as an MLL-fusion nucleolar partner without the words 'not in the MLL-AF4 column', the graph will have repeated the pooled-for-per-bait error it retracted last cycle.
- RRP12 is in six of seven fusion interactomes and absent from the index fusion's. Is that biology or detection depth? The raw files at PXD009338 contain the MLL-AF4 runs; re-searching them specifically for RRP12 peptides at relaxed stringency would answer it with no wet work and would set the pattern for the other five block members in the same position.
- Yeast Rrp12 exports pre-40S with Crm1, and this repo carries a separate XPO1/CRM1 export-axis thread built on entirely different evidence. Do the two axes touch, or is the shared exportin a coincidence of a housekeeping pathway? Worth one deliberate look precisely because it is the kind of adjacency that gets asserted without being tested.
- RRP12 acquired a recessive human disease in 2025 with no blood phenotype. Are the patients' haematological indices reported anywhere in that cohort work? A ribosomopathy-adjacent gene with an unexamined blood phenotype in an existing patient cohort is a cheap question to ask of the authors.
- E1weak confidence 2 of 5: Preliminary, small, indirect, or not yet peer reviewed.paper
RRP12 co-purified with six of the seven Strep-HA-tagged MLL fusions in isogenic human Jurkat T-ALL cells - MLL-AF1p, MLL-AF9, MLL-CBP, MLL-EEN, MLL-ENL and MLL-GAS7 - and is ABSENT from the MLL-AF4 (= KMT2A::AFF1) column entirely, with no p-value and no spectral count under the index bait; the negative control is zero spectra.
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. · Skucha A, Ebner J, Schmöllerl J, Roth M, Eder T, César-Razquin A, Stukalov A, Vittori S, Muhar M, Lu B, Aichinger M, Jude J, Müller AC, Győrffy B, Vakoc CR, Valent P, Bennett KL, Zuber J, Superti-Furga G, Grebien F · Nat Commun 2018What this evidence cannot show
THE INDEX FUSION DID NOT RECOVER THIS PROTEIN. RRP12 is absent from the MLL-AF4 column of Supplementary Table 5 entirely -- there is no p-value and no spectral count for it under the index bait. It is an MLL-FUSION interactor, not a demonstrated KMT2A::AFF1 interactor, and nothing in this entry should be read as a KMT2A::AFF1 contact. The 6 baits that did recover it are MLL-AF1p, MLL-AF9, MLL-CBP, MLL-EEN, MLL-ENL, MLL-GAS7. Negative control: ZERO spectra. THE HEADLINE OF THIS ENTRY, AND IT BELONGS IN EVERY QUOTATION OF IT: this protein is NOT in the MLL-AF4 column. It is an MLL-FUSION interactor and NOT a demonstrated KMT2A::AFF1 interactor. Five of the eleven nucleolar-block proteins written by this beat are in that position - RRP12, WDR18, UTP14A, RRP9 and FTSJ3 - plus UTP18, six in total. The 'thirteen-protein nucleolar block' is a POOLED statement over seven baits; in the index fusion's own column there are seven members and four below p = 0.05. TWO READINGS, NEITHER ESTABLISHED: MLL-AF4 is the shallowest bait, so absence may be a detection-depth artefact; or RRP12 may genuinely not associate with the index fusion. The experiment cannot distinguish them. FUNCTIONAL SCREEN. Supplementary Data 2 (MOESM5) is the shRNA library for the negative-selection screen: 768 data rows, 128 unique gene symbols, EXACTLY six shRNAs each -- counted with openpyxl by this beat on 2026-09-21, and this protein's symbol IS in it with six shRNAs. So it was functionally tested against an MLL fusion (MLL-AF9 in MOLM-13), which is more than a co-purification. But per-gene scores are published only as the heatmaps in Fig. 2c/2d with no table anywhere in the paper or its five supplementary files, so the outcome for this protein is not recoverable: measured-not-reported. THE BLOCK, re-measured by this beat on 2026-09-21 by re-running analyses/mll-fusion-interactome-complexes/run.py. A 26-subunit nucleolar / ribosome-biogenesis set returns 15 of 26 present in the 960-protein network against 1.25 expected by chance, hypergeometric p = 6.99e-14, q(BH) = 8.39e-13 across the twelve complexes tested -- the TOP-RANKED complex in the whole interactome, ahead of the CCT/TRiC negative control (q = 1.4e-09) and the SEC positive control (q = 1.5e-09). The fifteen are FBL, FTSJ3, GNL2, LYAR, NOLC1, NOP2, NOP58, PA2G4, RRP12, RRP9, TBL3, TCOF1, UTP14A, UTP18, WDR18. BUT THE BACKGROUND IS THE ~20,000-PROTEIN PROTEOME, not the ~4,600 proteins the study actually recovered before filtering, so every q here is an UPPER BOUND on significance and it is loosest for a complex of abundant nuclear proteins -- which this one is, more than any other row in that table. AND THE POOLED NUMBER IS NOT THE PER-BAIT NUMBER. Subunits of the block recovered per bait, out of 26: MLL-AF1p 8, MLL-AF4 7, MLL-AF9 12, MLL-CBP 10, MLL-EEN 12, MLL-ENL 11, MLL-GAS7 7. The index fusion is TIED LAST. In its column there are seven members and only four at p<0.05 -- GNL2, NOP2, PA2G4 and TBL3; LYAR (0.141), NOLC1 (0.134) and TCOF1 (0.163) are above it. So the strongest complex-level signal in this entire interactome is weakest in the fusion this project studies. SYSTEM: the AP-MS host is JURKAT, a human T-ALL line, while KMT2A::AFF1 disease is B-lineage infant leukaemia; a partner requiring a B-cell or infant proteome cannot appear here and a T-lineage partner can appear spuriously. The bait is a Strep-HA-tagged, SINGLE-COPY, doxycycline-induced transgene at an FRT/Flp cassette, not the endogenous fusion. Prey came from bulk nuclear lysate after a single STREP-Tactin step, so co-purification is NOT evidence of a direct contact. INCLUSION RULE: the paper kept the top 300 interactions per bait by combined p-value rather than applying a p threshold (Methods, verbatim: "All the identified bait-prey pairs were ranked by the combined p-value. The 300 most significant interactions per bait were retained."). In the MLL-AF4 column 186 of 291 listed p-values (63.9%) exceed 0.05; the pooled rate over all baits is 26.6%, and the pooled rate must NOT be quoted for a per-bait claim. BAIT DEPTH: MLL-AF4 is the shallowest of the seven baits by spectral counts, so a low or absent MLL-AF4 count is a property of the bait (transgene expression, purification depth, normalisation) and must not be read as a weaker association. ABUNDANCE IS THE LEADING ALTERNATIVE EXPLANATION. The nucleolus is the densest compartment in the nucleus, every bait here is a tagged nuclear protein, and the complex-level analysis in this repo exists to make exactly that point: its strongest per-bait signature in the index fusion's own column is CCT/TRiC, a canonical AP-MS contaminant, at 8 of 9 subunits with 6 at p<0.05 -- BETTER represented in MLL-AF4's column than the nucleolar block is. Complex-wide enrichment is not by itself evidence of specific binding. THE ARGUMENT ON THE OTHER SIDE: all thirteen members of the nucleolar block, this protein included, have a negative control of ZERO spectra. A non-specific sticky abundant protein would be expected to appear in the control purification too, and none of them does. That is the strongest single fact about this block and it is not explained by abundance alone. SELECTIVITY: the paper's own named NON-selectivity controls are RFC1, SF3A3 and CCT3 -- knockdown inhibited MLL-wild-type K562 and HL-60 as much as MOLM-13 -- against MEN1 as the selective positive. This protein is not among them. That is NOT evidence of selectivity: only 40 of the 128 entered the MLL-r versus MLL-wild-type re-screen and the paper does not say which 40, so absence from the control list is equally consistent with never having reached the second screen. Recorded as UNKNOWN. This entry does not nominate a target. Per-bait membership re-derived by this beat on 2026-09-21 by re-running analyses/skucha-mll-fusion-interactome/run.py (both controls PASS: 128 shared by >=5 baits, 42 by all seven, MEN1 present with all seven) and analyses/mll-fusion-interactome-complexes/run.py. n_fusions and the MLL-AF4 p-value were supplied pre-verified by the coordinator from the cached MOESM4 xlsx and were independently reproduced by this beat's re-run of the complex analysis.
Evidence that argues against this (2)
- IntAct has never curated this dataset, so no independent curator has re-examined these calls and no interactome-coverage metric built on IntAct can see them; the raw spectra at ProteomeXchange PXD009338 have not been reanalysed here. The authors themselves removed seven proteins from the shared set by hand as frequently observed contaminants, which concedes that a rank cutoff lets contaminants through. ProteomeXchange/PRIDE 2018
- The same paper that motivates the nucleolar reading supplies its null hypothesis: MLL-AF4 is reported predominantly nucleolar, so every abundant nucleolar protein becomes a high-probability co-purification partner on compartment grounds alone. And the prediction that reading makes fails -- if nucleolar residency of the bait drove recovery, the index fusion should pull MORE of the block than the other six baits, and it pulls the FEWEST (7 of 26, tied last with MLL-GAS7). The report is also an ectopic-overexpression system, which this project treats as weak evidence about an endogenous protein. Siemund AL et al. 2022
- E2strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
Yeast Rrp12 is required for the exit of pre-40S particles to the cytoplasm and for proper maturation dynamics of upstream 90S pre-ribosomes; its elimination causes accumulation of nucleoplasmic 90S-to-pre-40S transitional particles, abnormal 35S pre-rRNA processing and no export of intermediate pre-40S complexes, and the exportin Crm1 is required for the same step.
Rrp12 and the Exportin Crm1 participate in late assembly events in the nucleolus during 40S ribosomal subunit biogenesis. · Moriggi G, Nieto B, Dosil M · PLoS Genet 2014What this evidence cannot show
SACCHAROMYCES CEREVISIAE, 2014 PLoS Genetics. Not human, not leukaemia, not a fusion. Read from the abstract only. Cited for molecular function, which transfers reasonably across eukaryotes for a conserved ribosome-biogenesis factor, but the human protein's role has not been demonstrated to be identical. The Crm1 co-requirement is noted because this repo carries an export-axis/XPO1 thread - that is a TOPICAL ADJACENCY and not a connection: nothing here involves a fusion protein.
Evidence that argues against this (1)
- A conserved export factor is required in every eukaryotic cell that makes ribosomes, so nothing about this function predicts a specific relationship with a leukaemia fusion. It also makes RRP12 abundant and constitutively associated with large pre-ribosomal particles, which is the profile most likely to be recovered non-specifically from a nuclear lysate. Skucha A et al. 2018
- E3moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper
A yeast functional screen found that Rrp12, a preribosomal maturation and export factor, additionally has roles in cell cycle progression and the DNA damage response that are unrelated to ribosome synthesis, involving a karyopherin Kap121-dependent import route.
Ribosome synthesis-unrelated functions of the preribosomal factor Rrp12 in cell cycle progression and the DNA damage response. · Dosil M · Mol Cell Biol 2011What this evidence cannot show
SACCHAROMYCES CEREVISIAE, 2011 Molecular and Cellular Biology, a single-author functional screen. Not human, not leukaemia, not a fusion. Read from the abstract only. Separating intra- from extra-ribosomal roles is explicitly stated by the paper as difficult, so an 'unrelated' function claimed from a screen in a ribosome-biogenesis mutant background should be held loosely - a cell-cycle phenotype is the expected downstream consequence of impaired ribosome production, which is the confound the paper is trying to exclude.
Evidence that argues against this (1)
- The straightforward alternative explanation is the one the paper is arguing against: a cell that cannot make ribosomes properly will have cell-cycle and stress phenotypes for that reason alone. Calling them ribosome-synthesis-unrelated requires separating two things the paper concedes are hard to separate, and no human or vertebrate work this beat found replicates the extra-ribosomal claim. Moriggi G et al. 2014
- E4moderate confidence 3 of 5: One strong study, or several smaller consistent ones.paper
Biallelic RRP12 variants are associated with autosomal recessive primary brain calcifications: exome sequencing of two unrelated Pakistani patients with generalized dystonia and primary brain calcifications identified RRP12, which was then investigated in French (n = 111) and Chinese (n = 543) brain-calcification cohorts.
RRP12 Variants Are Associated With Autosomal Recessive Brain Calcifications. · Monfrini E, Rinchetti P, Anheim M, Klingseisen A, Lagha-Boukbiza O, Cen Z, Yang D, Chen X, Maroofian R, Houlden H, Cappelletti G, Richard AC, Quenez O, Toro C, Frucht SJ, Lotti F, Luo W, Hunt D, Nicolas G, Riboldi GM · Mov Disord 2025What this evidence cannot show
HUMAN genetics, 2025 Movement Disorders. Not leukaemia, not a fusion, and NO HAEMATOPOIETIC PHENOTYPE IS REPORTED - this is a neurological and calcific disorder, and nothing in it supports a blood-lineage inference for RRP12. The discovery arm is two patients from two families, which is small; the cohort arms are the replication attempt and this beat read only the abstract, so how many additional cases the two cohorts yielded is NOT recorded here and must not be assumed. Cited for two things: RRP12 loss of function has human consequences, and this paper is the current experimental (ECO:0000269) citation behind UniProt's nucleolar localisation call for human RRP12.
Evidence that argues against this (1)
- This entry deliberately does NOT parallel it with TBL3. TBL3's zebrafish mutant loses T cells and haematopoietic stem/progenitor cells, which is why that protein's loss-of-function phenotype is treated as lineage-relevant in this graph. RRP12's human phenotype is neurological with no blood component reported, so the two are not comparable and RRP12 must not inherit TBL3's relevance argument by association within the same block. Skucha A et al. 2018
- E5moderate confidence 3 of 5: One strong study, or several smaller consistent ones.database
PubMed returns zero records naming RRP12 or KIAA0690 together with KMT2A, MLL, MLL-AF4, MLL-AF9 or t(4;11) in title or abstract, against a positive control of 85 for MEN1 through the identical query shape and 38 records for the bare RRP12 operand.
NCBI PubMed esearch, bounded-absence query (counted negative) · NCBI E-utilities 2026What this evidence cannot show
A counted negative with a date, the exact query, the querytranslation and the tool. Bounded by TITLES AND ABSTRACTS ONLY - supporting figures not searched (rule 80). The retired/clone symbol KIAA0690 was searched deliberately per the retired-symbol rule, because RRP12's older literature predates the current symbol. Bare operand 38, so the instrument can return a one.
Evidence that argues against this (1)
- RRP12 is one of the 128 conserved interactors shRNA-screened in MLL-AF9 MOLM-13 with six shRNAs in the source paper itself, so a functional measurement against an MLL fusion exists and was never tabulated. Note the asymmetry this creates for this particular protein: it was functionally SCREENED against MLL-AF9 while never having been BOUND by the index fusion - the functional record here is stronger than the binding record, which is the reverse of the usual situation in this block. Skucha A et al. 2018
both in the nucleolar block; RRP12 at 6 of 7 baits but ABSENT from the MLL-AF4 column
- related to →KMT2A::AFF1 (MLL-AF4), t(4;11)(q21;q23)
NOT recovered by MLL-AF4 - an MLL-fusion interactor, not a demonstrated KMT2A::AFF1 interactor
joint-second on the pooled count (6 of 7 each) and opposite in the index column: LYAR present at p=0.141, RRP12 absent
- related to →The nucleolus — the one compartment with direct published images of a KMT2A fusion inside it
pre-40S export factor in the MLL-fusion interactome; its absence from the index column is counter-evidence for the convergence
both absent from the index fusion's column while present in five or six others